Clinical and Translational Immunology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q3 | 49.7% | 1.312 | Q1 | 89.8% |
| 2024 | 3.8 | Q2 | 62.5% | 1.472 | Q1 | 91.9% |
| 2023 | 4.6 | Q2 | 66.3% | 1.705 | Q1 | 94.2% |
| 2022 | 5.8 | Q2 | 68.8% | 1.908 | Q1 | 95.3% |
| 2021 | 6.5 | Q2 | 70.8% | 1.771 | Q1 | 94.9% |
| 2020 | — | — | 2.321 | Q1 | 96.5% | |
| 2019 | — | — | 2.833 | Q1 | 97.6% | |
| 2018 | — | — | 3.032 | Q1 | 97.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2050-0068
country
coverage
2012-2026
